EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Posterior reversible encephalopathy syndrome (PRES) in classic Hodgkin’s lymphoma, complicated by anthracycline-induced cardiomyopathy

Rose Hall, Bambang Atmaja, Bhupinder Sharma, David Cunningham

BMJ Case Reports · 2024-08 · 17 (8) · e257523

DOI: 10.1136/bcr-2023-257523 ↗

Kurz gefasst

Fallbericht in der Zeitschrift BMJ Case Reports, online erschienen am 14.08.2024. Verfasst von Rose Hall und 3 weiteren Autor:innen. Beteiligte Einrichtung: Royal Marsden Hospital NHS Trust, Chelsea, UK rose.hall@doctors.org.uk. Hauptthemen laut MEDLINE: Hodgkin Disease, Posterior Leukoencephalopathy Syndrome, Antineoplastic Combined Chemotherapy Protocols, Cardiomyopathies. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A woman in her 20s with no medical history was diagnosed with bulky stage II classic Hodgkin’s lymphoma after an 8-week history of shortness of breath, cough and lethargy. A regimen of doxorubicin (Adriamycin), bleomycin, vinblastine and dacarbazine (ABVD) was commenced with six cycles planned. During the first cycle, the patient was profoundly hypertensive. She then suffered two self-terminating tonic-clonic seizures. Examination and investigations diagnosed posterior reversible encephalopathy syndrome (PRES), which resolved completely in 11 days with strict blood pressure control and withholding chemotherapy. Treatment was further complicated by anthracycline-induced cardiomyopathy, requiring a switch in regimen to gemcitabine BVD. The patient made a full recovery from neurology and cardiology perspectives and completed six cycles of chemotherapy, achieving a complete metabolic response by the tumour. We illustrate the case, describe differential diagnoses and management of PRES, its association with chemotherapy and the successful chemotherapy rechallenge.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hodgkin DiseasePosterior Leukoencephalopathy SyndromeAntineoplastic Combined Chemotherapy ProtocolsCardiomyopathiesDoxorubicinDacarbazineBleomycinVinblastineHumansFemaleAdultDiagnosis, DifferentialAnthracyclinesGemcitabineMagnetic Resonance Imaging

Stichwörter der Autor:innen

Cancer interventionDrugs: CNS (not psychiatric)Epilepsy and seizuresHaematology (incl blood transfusion)Oncology

Substanzen

DoxorubicinDacarbazineBleomycinVinblastineAnthracyclinesGemcitabine

Autor:innen und Institutionen

  • Royal Marsden Hospital NHS Trust, Chelsea, UK rose.hall@doctors.org.uk.
  • Royal Marsden Hospital NHS Trust, Chelsea, UK.

Zitieren

APA

Hall, R., Atmaja, B., Sharma, B., & Cunningham, D. (2024). Posterior reversible encephalopathy syndrome (PRES) in classic Hodgkin’s lymphoma, complicated by anthracycline-induced cardiomyopathy. BMJ Case Reports, 17(8), e257523. https://doi.org/10.1136/bcr-2023-257523

Vancouver

Hall R, Atmaja B, Sharma B, Cunningham D. Posterior reversible encephalopathy syndrome (PRES) in classic Hodgkin’s lymphoma, complicated by anthracycline-induced cardiomyopathy. BMJ Case Reports. 2024;17(8):e257523. doi:10.1136/bcr-2023-257523

BibTeX
@article{Hall2024,
  author = {Hall, Rose and Atmaja, Bambang and Sharma, Bhupinder and Cunningham, David},
  title = {Posterior reversible encephalopathy syndrome (PRES) in classic Hodgkin’s lymphoma, complicated by anthracycline-induced cardiomyopathy},
  journal = {BMJ Case Reports},
  year = {2024},
  volume = {17},
  number = {8},
  pages = {e257523},
  doi = {10.1136/bcr-2023-257523}
}
Kostenlos starten →